Elevated alpha fetoprotein is a hallmark laboratory finding in Ataxia Telangiectasia.
Ataxia Telangiectasia is a rare, progressive, autosomal recessive disorder caused by mutations in the ATM gene (11q).
It combines features of a neurodegenerative disorder, immunodeficiency, and cancer predisposition. π§¬
- ATM gene encodes a protein kinase critical for DNA repair and cell cycle control. β‘
- Loss of ATM function β defective DNA repair, genomic instability, and radiation sensitivity. β’οΈ
- Hallmark triad: progressive cerebellar ataxia, oculocutaneous telangiectasia, and immunodeficiency.
π§© Aetiology & Pathophysiology
- ATM mutation β defective phosphatidylinositol-3-kinaseβrelated kinase function β impaired DNA double-strand break repair.
- β Cerebellar degeneration: loss of Purkinje & granular cells β progressive ataxia.
- π¦ Immunodeficiency: T-cell and B-cell dysfunction β recurrent infections.
- ποΈ Oncogenesis: markedly β risk of lymphoid malignancies (esp. NHL, Hodgkin, leukaemia).
- π¨ Pulmonary complications: chronic chest infections β bronchiectasis.
π©ββοΈ Clinical Presentation
- π§ Onset before age 10 with progressive neurological decline.
- Ataxia: gait unsteadiness, poor coordination, frequent falls.
- Apraxia of gaze: child turns head instead of moving eyes β highly suggestive exam clue π.
- Movement disorders: chorea, athetosis, myoclonic jerks.
- Telangiectasias: dilated vessels on bulbar conjunctiva & skin (e.g. ears, nose, cheeks). π
- Recurrent infections: sinusitis, pneumonia, bronchiectasis.
- Endocrine: hypogonadism, delayed puberty.
- Lymphadenopathy / fevers: possible lymphoma.
β οΈ Complications
- ποΈ Very high risk of B-cell and T-cell lymphomas + leukaemias.
- β risk of solid tumours, esp. breast and lung cancers (also in heterozygous carriers).
- Chronic respiratory disease from recurrent infections.
- Progressive neurodegeneration β severe disability.
π Investigations
- π Alpha-fetoprotein (AFP): elevated (diagnostic hallmark).
- π§ͺ Immunoglobulins: β IgA, IgE, IgG2, IgG4 (variable immune deficiency).
- π§ MRI Brain: cerebellar atrophy, enlarged 4th ventricle, widened sulci.
- 𧬠Genetic testing: confirms ATM mutations.
βοΈ Management
- β No cure β treatment is supportive.
- π Infection prevention: prophylactic antibiotics, IVIG replacement if severe hypogammaglobulinaemia.
- π« Respiratory support: chest physiotherapy, bronchodilators, early treatment of infections.
- ποΈ Cancer surveillance: close monitoring for lymphomas/leukaemias.
- π§βπ€βπ§ Genetic counselling: autosomal recessive inheritance; carriers have β breast cancer risk.
- β οΈ Avoid unnecessary radiation exposure (diagnostic & therapeutic) due to radiosensitivity.
π Prognosis
Life expectancy is limited β many patients do not survive beyond their early 20s due to infections or malignancy.
Supportive multidisciplinary care (neurology, immunology, oncology, respiratory) is vital to improve quality of life.
π References
π‘ Exam Pearl
Child with ataxia, ocular telangiectasia, recurrent infections, βAFP β think **Ataxia-Telangiectasia**.
Always mention **lymphoma risk** and **radiation sensitivity** in exams. π―